|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Piazuelo MB and Correa P: Gastric cáncer:
Overview. Colomb Med (Cali). 44:192–201. 2013.PubMed/NCBI
|
|
4
|
Matuszcak C, Haier J, Hummel R and Lindner
K: MicroRNAs: Promising chemoresistance biomarkers in gastric
cancer with diagnostic and therapeutic potential. World J
Gastroenterol. 20:13658–13666. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shi J, Qu YP and Hou P: Pathogenetic
mechanisms in gastric cancer. World J Gastroenterol.
20:13804–13819. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
John B, Enright AJ, Aravin A, Tuschl T,
Sander C and Marks DS: Human MicroRNA targets. PLoS Biol.
2:e3632004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li PF, Chen SC, Xia T, Jiang XM, Shao YF,
Xiao BX and Guo JM: Non-coding RNAs and gastric cancer. World J
Gastroenterol. 20:5411–5419. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ueda T, Volinia S, Okumura H, Shimizu M,
Taccioli C, Rossi S, Alder H, Liu CG, Oue N, Yasui W, et al:
Relation between microRNA expression and progression and prognosis
of gastric cancer: A microRNA expression analysis. Lancet Oncol.
11:136–146. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pang Y, Young CY and Yuan H: MicroRNAs and
prostate cancer. Acta Biochim Biophys Sin (Shanghai). 42:363–369.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Feng R, Chen X, Yu Y, Su L, Yu B, Li J,
Cai Q, Yan M, Liu B and Zhu Z: miR-126 functions as a tumour
suppressor in human gastric cancer. Cancer Lett. 298:50–63. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Qiao F, Zhang K, Gong P, Wang L, Hu J, Lu
S and Fan H: Decreased miR-30b-5p expression by DNMT1 methylation
regulation involved in gastric cancer metastasis. Mol Biol Rep.
41:5693–5700. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Singh P, Alex JM and Bast F: Insulin
receptor (IR) and insulin-like growth factor receptor 1 (IGF-1R)
signaling systems: Novel treatment strategies for cancer. Med
Oncol. 31:8052014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
King H, Aleksic T, Haluska P and Macaulay
VM: Can we unlock the potential of IGF-1R inhibition in cancer
therapy? Cancer Treat Rev. 40:1096–1105. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Crudden C, Girnita A and Girnita L:
Targeting the IGF-1R: The tale of the tortoise and the hare. Front
Endocrinol (Lausanne). 6:642015.PubMed/NCBI
|
|
18
|
Chen HX and Sharon E: IGF-1R as an
anti-cancer target-trials and tribulations. Chin J Cancer.
32:242–252. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Morishita A, Gong J and Masaki T:
Targeting receptor tyrosine kinases in gastric cancer. World J
Gastroenterol. 20:4536–4545. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ge J and Chen Z, Huang J, Yuan W, Den Z
and Chen Z: Silencing insulin-like growth factor-1 receptor
expression inhibits gastric cancer cell proliferation and invasion.
Mol Med Rep. 11:633–638. 2015.PubMed/NCBI
|
|
21
|
Wittekind C: The development of the TNM
classification of gastric cancer. Pathol Int. 65:399–403. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Visone R, Pallante P, Vecchione A,
Cirombella R, Ferracin M, Ferraro A, Volinia S, Coluzzi S, Leone V,
Borbone E, et al: Specific microRNAs are downregulated in human
thyroid anaplastic carcinomas. Oncogene. 26:7590–7595. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhu J, Zeng Y, Xu C, Qin H, Lei Z, Shen D,
Liu Z and Huang JA: Expression profile analysis of microRNAs and
downregulated miR-486-5p and miR-30a-5p in non-small cell lung
cancer. Oncol Rep. 34:1779–1786. 2015.PubMed/NCBI
|
|
25
|
Wang K, Jia Z, Zou J, Zhang A, Wang G, Hao
J, Wang Y, Yang S and Pu P: Analysis of hsa-miR-30a-5p expression
in human gliomas. Pathol Oncol Res. 19:405–411. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kimura S, Naganuma S, Susuki D, Hirono Y,
Yamaguchi A, Fujieda S, Sano K and Itoh H: Expression of microRNAs
in squamous cell carcinoma of human head and neck and the
esophagus: miR-205 and miR-21 are specific markers for HNSCC and
ESCC. Oncol Rep. 23:1625–1633. 2010.PubMed/NCBI
|
|
27
|
Jia Z, Wang K, Wang G, Zhang A and Pu P:
MiR-30a-5p antisense oligonucleotide suppresses glioma cell growth
by targeting SEPT7. PLoS One. 8:e550082013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang X, Wang K, Han L, Zhang A, Shi Z,
Zhang K, Zhang H, Yang S, Pu P, Shen C, et al: PRDM1 is directly
targeted by miR-30a-5p and modulates the Wnt/β-catenin pathway in a
Dkk1-dependent manner during glioma growth. Cancer Lett.
331:211–219. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Baraniskin A, Birkenkamp-Demtroder K,
Maghnouj A, Zöllner H, Munding J, Klein-Scory S, Reinacher-Schick
A, Schwarte-Waldhoff I, Schmiegel W and Hahn SA: MiR-30a-5p
suppresses tumor growth in colon carcinoma by targeting DTL.
Carcinogenesis. 33:732–739. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dai H, Kang B, Zuo D and Zuo G: Effect of
miR-30a-5p on the proliferation, apoptosis, invasion and migration
of SMCC-7721 human hepatocellular carcinoma cells. Zhonghua Gan
Zang Bing Za Zhi. 22:915–920. 2014.(In Chinese). PubMed/NCBI
|
|
31
|
Li X, Zhang Y, Ding J, Wu K and Fan D:
Survival prediction of gastric cancer by a seven-microRNA
signature. Gut. 59:579–585. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yue L, Wang Y, Wang H, Gao H, Liang J, Sui
A, Xiang J, Zhou F, Xu C, Zhao W, et al: Inhibition of
hepatocellular carcinoma cell growth by an anti-insulin-like growth
factor-I receptor monoclonal antibody. Oncol Rep. 28:1453–1460.
2012.PubMed/NCBI
|
